Tumors With CDK4/6 Pathway Activation clinical trials at UC Davis
1 research study open to eligible people
open to eligible people ages 18 years and up
The purpose of this signal seeking study was to determine whether treatment with LEE011 demonstrates sufficient efficacy in CDK4/6 pathway activated solid tumors and/or hematologic malignancies to warrant further study.
Sacramento, California and other locations